<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.949" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">485</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285â€“496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 639.300 L100.110 639.300 "/>
  <g begin="text">
   <text y="77.103" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="77.103" x="118.162,124.66,127.162,131.158,138.16,140.662,145.162,149.158,153.658,160.66,164.656,169.156,171.406,173.656,176.86,180.856,183.106,186.31,190.81,193.312,197.812,202.312,204.814,209.314,211.564,214.768,218.764,221.599,224.596,228.592,232.588,235.09,237.592,242.092,246.088,248.338,251.542,254.044,257.041,261.037,265.033,267.535,274.537,278.533,283.033,285.535,287.785,290.989,293.491,297.991" svgx:width="0.72,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.44,0.25,0.55,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Alemtuzumab, a highly effective treatment in </text>
   <text y="88.101" x="62.362,65.359,69.355,71.857,75.853,80.353,83.854,86.356,90.856,95.356,97.696,100.693,104.689,111.691,114.193,116.695,119.197,121.699,126.199,130.699,133.039,140.041,144.541,147.043,149.545,152.047,156.547,159.049,163.045,165.385,168.886,172.882,175.384,179.38,182.377,186.877,190.378,192.88,196.381,198.721,201.718,207.721,213.724,221.725,226.729,229.726,231.976,234.316,236.818,240.319,242.659,246.655,250.156,253.657,258.157,262.153,264.655,268.651,271.153,275.149,279.649,281.989,288.487,290.989,293.491,297.991" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.28,0.5,0.5,0.25,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.67,0.67,0.89,0.56,0.33,0.25,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapsing remitting multiple sclerosis (RRMS), is associated with </text>
   <text y="99.099" x="62.362,66.358,68.608,71.11,75.61,80.11,84.61,87.607,91.108,93.61,97.606,102.106,106.606,109.108,113.608,118.108,120.358,122.86,127.36,134.362,138.862,143.362,147.862,152.362,156.358,160.858,163.36,167.356,169.606,171.856,176.356,180.352,183.349,185.851,188.353,192.349,196.849,199.351,203.347,206.344,208.846,213.346,215.596,220.096,223.093,225.181,230.518,232.768,238.771,245.269,249.769,254.845,257.095,260.596,265.096,269.596,273.097,277.093,279.595" svgx:width="0.44,0.25,0.28,0.5,0.5,0.5,0.33,0.39,0.28,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.25,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.25,0.5,0.33,0.25,0.61,0.25,0.67,0.72,0.5,0.56,0.25,0.39,0.5,0.5,0.39,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a long-standing lymphopenia, particularly of T CD4+ subset.</text>
   <text y="110.097" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="110.097" x="108.1,112.969,117.469,119.719,124.219,128.215,130.717,134.713,137.71,144.712,147.214,151.714,155.71" svgx:width="0.61,0.5,0.25,0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To determine:</text>
   <text y="127.098" x="76.366,80.866,83.863,86.113,94.366,99.037,102.034,106.03,110.026,112.528,115.03,117.28,121.78,126.28,130.276,134.776,139.276,141.778,146.278,150.778,153.28,157.276,159.526,163.522,168.022,172.522,174.772,177.769,182.269,186.769,190.765,193.267,195.769,200.269,204.769,208.765,211.267,213.517,217.513,222.013,226.009,228.511,233.011,236.512,239.014,242.515" svgx:width="0.5,0.33,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.25,0.5,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">1) T-cell phenotypic and functional analysis;</text>
   <text y="138.096" x="76.366,80.866,83.863,86.113,94.366,98.362,102.862,105.364,109.864,114.364,116.866,121.366,125.362,127.612,129.862,131.851,135.847,140.347,144.343,151.345,155.845,160.345,162.847,167.347,171.343,173.593,175.843,177.832,181.828,186.328,190.828,193.078,195.067,199.063,203.563,207.559,214.561,219.061,223.561,226.063,230.563,234.559,236.809,238.798,241.795,245.791,249.787,253.783,258.283,260.785,265.285,268.282,270.532,272.521,279.523,285.526,292.024,298.027" svgx:width="0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.25,0.55,0.44,0.5,0.44,0.78,0.5,0.5,0.28,0.5,0.44,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.44,0.78,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.55,0.78,0.67,0.72,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2) cytokine, chemokine, and chemokine receptor mRNA </text>
   <text y="149.094" x="94.366,96.868,100.864,105.364,109.36,111.862,115.363,117.613,126.532,130.528,133.525,136.027,140.023,143.02,145.27,154.18,158.176,160.678,164.674,171.676,174.178,178.678,182.674,187.174,194.176,198.172,202.672,204.922,213.832,216.334,220.834,223.084,232.003,238.006,244.009,252.01,257.014,259.516,264.016,268.516,271.513,278.515,283.015,287.515,290.017,294.517,298.018" svgx:width="0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.67,0.67,0.89,0.56,0.28,0.5,0.5,0.33,0.78,0.5,0.5,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">levels after alemtuzumab in RRMS:24-months </text>
   <text y="160.092" x="94.366,97.363,101.863,104.365,106.867,111.367,117.865,120.862,125.362,129.862" svgx:width="0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">follow-up.</text>
   <text y="177.093" x="62.362,70.768,74.674,77.581,82.495,86.905,91.819,95.23,98.137" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="177.093" x="101.386,109.297,113.707,116.119,118.531,120.943,124.849,128.755,133.165,135.577,139.483,142.39,144.64,145.639,150.049,154.459,156.709,157.708,164.62,169.03,173.44,175.852,180.262,183.673,185.923,186.922,189.829,194.239,196.651,199.063,203.473,209.881,212.788,217.198,221.608,223.858,224.857,229.267,232.174,234.424,235.423,239.833,244.243,246.493,247.492,251.398,253.81,257.716,264.628,267.04,271.45,275.356,279.766,286.678,290.584,294.994" svgx:width="0.89,0.5,0.28,0.28,0.28,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.5,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Multicenter 24 months follow-up of 29 alemtuzumab-</text>
   <text y="188.091" x="62.362,64.774,67.681,71.587,75.493,77.905,81.811,86.221,88.129,94.042,99.955,107.866,112.78,114.688,119.098,123.004,125.416,127.828,131.734,136.144,138.556,141.967,143.875,146.287,150.697,152.605,158.518,164.926,172.837,180.748,185.662,187.57,191.98,196.39,200.8,202.708,207.118,210.025,211.933,216.343,220.753,225.163,227.071,229.483,232.39,234.802,238.708,241.12,244.531,246.691,248.599,253.513,255.925,260.335,264.745,267.652,271.558,274.969,278.875,282.781,287.191,291.097,295.003" svgx:width="0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.67,0.67,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.67,0.72,0.89,0.89,0.56,0.25,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.28,0.33,0.28,0.44,0.28,0.39,0.25,0.25,0.56,0.28,0.5,0.5,0.33,0.44,0.39,0.44,0.44,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treated RRMS patients in CAMMS 323 or 324 trials. Fluorescence-</text>
   <text y="199.089" x="62.362,68.86,72.856,75.358,77.86,82.36,86.356,88.858,92.854,97.354,99.604,100.819,106.822,110.818,113.32,115.822,118.072,119.287,124.291,128.791,131.788,134.29,136.792,141.292,145.792,148.042,149.257,152.254,156.592,163.09,169.093,174.097,177.094,179.344,180.559,184.555,189.055,193.051,195.553,200.053,203.554,206.056,209.557,211.807,213.022,217.522,220.519,222.769,223.822,229.006,232.003,235.999,240.499,242.749,244.999,246.052,251.551,256.051,260.047,262.549,267.049,271.045,274.042,276.292,277.507,280.504,286.003,290.503,293.5,298.0" svgx:width="0.72,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.44,0.28,0.28,0.25,0.55,0.56,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.56,0.72,0.67,0.56,0.33,0.25,0.55,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.33,0.44,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.28,0.5,0.44,0.33,0.25,0.55,0.33,0.61,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Activated Cell Sorting (FACS) analysis of Treg, Thelper (Th)1 </text>
   <text y="210.087" x="62.362,66.358,70.858,75.358,77.608,83.629,89.128,93.628,98.128,102.628,104.878,111.061,115.057,119.053,121.555,124.057,127.558,129.808,132.058,138.241,141.238,148.24,155.242,159.742,164.242,168.742,171.244,175.744,180.244,182.746,186.742,190.738,193.24,195.49,201.673,208.675,213.175,215.677,219.673,223.669,228.169,230.671,234.667,236.917,243.1,250.102,256.105,262.603,268.606,270.856,277.039,279.541,283.537,288.037,292.033,294.535,298.036" svgx:width="0.44,0.5,0.5,0.25,0.55,0.61,0.5,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.33,0.78,0.78,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.25,0.55,0.78,0.67,0.72,0.72,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and Th17 cells. Immunological molecule mRNA levels </text>
   <text y="221.085" x="62.362,65.359,69.355,73.855,77.851,84.853,89.353,93.853,96.355,100.855,104.851,108.352,110.854,116.857,122.86,128.359,131.356,135.523,140.023,142.273,148.276,154.774,160.777,166.276,169.273,173.773,178.273,180.775,184.771,189.271,193.267,200.269,204.769,209.269,211.771,216.271,220.267,222.517,241.525,244.522,248.518,252.514,256.51,261.01,263.512,268.012,271.009,274.51,277.012,283.015,289.018,295.021" svgx:width="0.33,0.44,0.5,0.44,0.78,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.67,0.67,0.61,0.33,0.5,0.5,0.25,0.67,0.72,0.67,0.61,0.33,0.5,0.5,0.28,0.44,0.5,0.44,0.78,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.39,0.28,0.67,0.67,0.67,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(chemokines:CCL-11,CXCL-10;chemokine receptors:CCR-</text>
   <text y="232.083" x="62.362,66.862,69.112,75.115,81.118,87.121,90.118,94.618,97.12,98.947,102.943,107.443,109.945,114.445,118.945,121.447,125.947,129.943,133.444,135.946,138.943,143.947,150.445,154.423,156.673,162.172,168.67,173.674,178.255,180.505,186.004,192.502,197.506,202.222,204.472,207.469,212.968,215.965,220.465,225.046,227.296,230.293,235.792,238.789,243.289,245.539,248.536,254.035,257.032,261.532,263.782,266.779,272.278,275.275,279.775,284.275,286.525,289.522,295.021" svgx:width="0.5,0.25,0.67,0.67,0.67,0.33,0.5,0.28,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.33,0.56,0.72,0.44,0.25,0.61,0.72,0.56,0.51,0.25,0.61,0.72,0.56,0.52,0.25,0.33,0.61,0.33,0.5,0.51,0.25,0.33,0.61,0.33,0.5,0.25,0.33,0.61,0.33,0.5,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.33,0.61,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">4,CCR-6; cytokines:IFNÎ³,TGFÎ²,TNFÎ±,IL-1Î²,IL-2,IL-6,IL-10,IL-</text>
   <text y="243.081" x="62.362,68.05,73.738,79.426,85.114,90.802,93.052,94.24,97.21,98.425,105.112,108.082,109.297,114.985,120.673,128.359,130.609,131.797,134.767,135.982,142.669,145.639,146.854,152.542,158.23,163.702,165.952,167.14,170.10999999999999,171.325,178.012,183.7,189.388,191.638,192.826,195.796,197.011,203.698,206.668,207.883,213.571,219.259,221.509,222.697,225.667,226.882,233.569,236.539,237.754,243.442,249.13,251.38,252.568,255.538,256.753,263.44,266.41,267.625,273.313,279.001,281.52099999999996,282.691,286.65099999999995,287.875,293.563,298.063" svgx:width="0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.55,0.61,0.33,0.55,0.5,0.5,0.72,0.25,0.55,0.33,0.55,0.61,0.33,0.55,0.5,0.5,0.56,0.25,0.55,0.33,0.55,0.61,0.5,0.5,0.25,0.55,0.33,0.55,0.61,0.33,0.55,0.5,0.5,0.25,0.55,0.33,0.55,0.61,0.33,0.55,0.5,0.5,0.25,0.55,0.33,0.55,0.61,0.33,0.55,0.5,0.5,0.28,0.55,0.44,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">12p35, I L- 17A, I L- 17F, I L22, I L- 23, I L- 26, I L- 27; a nd </text>
   <text y="254.079" x="62.362,67.033,70.03,74.53,78.526,81.028,83.278,89.281,95.779,101.782,105.76,108.262,110.512,115.516,120.016,124.516,129.016,133.516,136.513,138.763,140.095,144.595,149.095,153.091,157.591,160.093,162.595,165.592,168.094,172.09,176.59,178.84,180.172,184.672,189.172,191.422,192.592,197.461,201.457,205.957,213.958,217.954,222.454,229.294,231.544,232.876,235.378,239.878,246.376,248.626,249.958,254.458,258.454,262.954,266.455,268.957,271.459,275.959,278.209,279.541,283.537,286.534,289.531,293.527,298.027" svgx:width="0.61,0.33,0.5,0.44,0.28,0.25,0.67,0.72,0.67,0.44,0.28,0.25,0.56,0.5,0.5,0.5,0.5,0.33,0.25,0.55,0.5,0.5,0.44,0.5,0.28,0.28,0.33,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.44,0.5,0.89,0.44,0.5,0.76,0.25,0.55,0.28,0.5,0.72,0.25,0.55,0.5,0.44,0.5,0.39,0.28,0.28,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">T-bet,RORÎ³t,Foxp3) quantified by TaqManÂ® low density array </text>
   <text y="265.077" x="62.362,65.359,70.858,76.357,82.855,89.353,92.35,94.213,97.21,101.206,105.202,107.704,110.701,113.203,115.705,122.707,126.703,128.566,133.066,137.566,140.068,144.568,151.57,155.566,158.563,162.559,166.06,170.056,171.919,175.915,180.415,184.411,186.913,191.413,193.276,196.273,200.269,204.265,208.261,210.763,213.265,217.765,222.265,224.128,226.63,231.13,232.993,239.491,243.991,248.491,250.993,254.989,256.852,261.352,263.854,268.354,272.854,277.354,279.604,281.305,286.489,289.486,293.482,297.982" svgx:width="0.33,0.61,0.61,0.72,0.72,0.33,0.25,0.33,0.44,0.44,0.28,0.33,0.28,0.28,0.78,0.44,0.25,0.5,0.5,0.28,0.5,0.78,0.44,0.33,0.44,0.39,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.25,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.72,0.5,0.5,0.28,0.44,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.61,0.33,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(TLDA) real-time polymerase chain reaction in whole blood. Treg </text>
   <text y="276.075" x="62.362,65.863,70.363,74.863,79.363,82.36,86.356,89.857,93.358,97.858,100.855,103.105,104.446,108.442,112.438,114.94,117.442,121.942,124.444,126.946,131.446,133.696,135.037,139.033,142.534,146.035,150.031,153.532,157.033,161.029,165.529,167.779,169.12,173.116,175.618,177.868,179.209,187.21,191.71,196.21,198.46,199.801,203.797,208.297,212.797,215.047,216.388,224.389,228.889,233.389,235.639,236.98,241.48,245.98,248.23,249.571,255.07,260.569,263.566,268.57,273.574,280.072,285.409,287.659,289.0,293.5,298.0" svgx:width="0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.5,0.33,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.89,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.61,0.33,0.56,0.56,0.72,0.61,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suppressor activity assessed at M12 and M24 by ELISPOT on </text>
   <text y="287.073" x="62.362,66.862,70.858,73.855,76.357,80.857,85.357,89.353,92.35,96.346,98.848,101.098,105.958,110.458,112.96,117.46,121.96,126.46,128.70999999999998,133.57,140.572,145.072,149.572,154.072,158.572,163.072,167.068,169.57,173.566,177.562,180.064,184.06,186.31,191.17,195.166,199.162,201.664,204.166,207.667,209.917,214.777,217.774,222.778,228.781,236.782,242.785,245.782,248.032,252.892,257.392,261.388,265.888,268.39,272.386,274.888,278.884,283.384,285.634,290.494,294.994,297.991" svgx:width="0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.44,0.28,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.33,0.56,0.67,0.89,0.67,0.33,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">peripheral blood mononucleate cells (PBMC) depleted of </text>
   <text y="298.071" x="62.362,68.365,74.863,79.363,83.863,88.363,90.865,95.365,99.865,102.034,107.371,109.702,113.698,117.694,120.196,122.698,126.199,128.53,132.526,137.026,141.526,143.857,147.853,151.849,154.351,156.853,161.353,165.349,167.851,171.847,176.347,178.678,185.176,187.678,190.18,194.68,197.011,204.013,208.513,212.509,215.011,217.513,222.013,224.344,228.844,232.84,236.341,238.843,242.839,245.17,249.67,252.667,257.167,259.669,263.665,266.167,270.667,272.998,275.995,283.996,289.999,295.003,298.0" svgx:width="0.67,0.72,0.5,0.5,0.5,0.28,0.5,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.78,0.5,0.44,0.28,0.28,0.5,0.25,0.5,0.44,0.39,0.28,0.44,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.33,0.89,0.67,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD25high T cells and activated with myelin basic protein (MBP) </text>
   <text y="309.069" x="62.362,66.862,69.859,72.109,74.179,78.175,82.675,85.177,87.679,90.676,96.679,103.177,107.677,110.674,116.677,123.175,127.675,132.175,134.425,136.675,138.583,143.767,146.269,153.271,157.267,161.767,166.267,168.769,173.269,175.771,179.272,181.774,184.024,186.094,192.097,196.093,199.594,203.59,206.092,208.594,213.094,217.09,219.34,221.41,224.407,228.907,232.903,235.9,240.4,243.397,247.393,249.643,251.713,254.71,257.212,260.209,263.71,266.212,268.462,270.532,274.528,277.03,281.026,288.028,290.53,295.03" svgx:width="0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.67,0.72,0.5,0.33,0.67,0.72,0.5,0.5,0.25,0.25,0.55,0.61,0.28,0.78,0.44,0.5,0.5,0.28,0.5,0.28,0.39,0.28,0.25,0.55,0.67,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.55,0.33,0.28,0.33,0.39,0.28,0.25,0.55,0.44,0.28,0.44,0.78,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">or anti-CD3-CD28. Timepoints: Baseline (before first alemtu-</text>
   <text y="320.067" x="62.362,66.358,70.858,77.86,81.856,86.356,88.606,92.161,96.067,100.477,104.887,107.794,111.205,115.111,118.018,120.43,128.341,132.751,137.161,139.573,143.983,146.233,149.698,152.605,160.516,163.423,165.673,169.138,173.548,175.708,177.958,181.423,189.334,193.744,198.154,200.314,202.564,206.029,213.94,218.35,222.76,224.92,227.17,230.635,238.546,242.956,247.366,249.778,252.028,255.493,258.4,262.306,265.717,270.127,274.033,277.939,280.351,282.763,287.173,291.079,293.491,297.991" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.33,0.28,0.89,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.89,0.33,0.25,0.55,0.5,0.25,0.25,0.55,0.89,0.5,0.5,0.25,0.25,0.55,0.89,0.5,0.5,0.25,0.25,0.55,0.89,0.5,0.5,0.28,0.25,0.55,0.33,0.44,0.39,0.5,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab course);Month (M) 6, M12, M18, M24: respectively </text>
   <text y="331.065" x="62.362,66.772,68.932,73.342,77.752,79.912,84.322,88.732,90.892,93.79,98.2,102.61,105.508,112.42,116.83,121.24,123.652,128.062,131.473,134.371,138.277,141.184,143.596,147.502,150.409,153.307,155.719,160.129,164.035,166.933,169.84,172.252,175.159,178.57,180.982,183.88,187.786,192.196,196.606,199.513,202.924,206.83,208.99,211.888,219.799,224.209,228.619,231.517,237.925,241.831,245.242,248.14,252.55,256.456,259.363,263.773,266.68,270.586,273.484,276.895,280.801,284.707,289.117,293.527,298.027" svgx:width="0.5,0.25,0.5,0.5,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.89,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.39,0.44,0.44,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">6,12,18, 24 months after the first course. M12 was before second </text>
   <text y="342.063" x="62.362,66.268,68.68,72.586,79.498,81.91,86.32,90.226,94.636,101.548,105.454,109.864,112.114,112.816,116.722,121.132,125.542,128.449,131.86,135.766,137.926,140.716,146.125,150.535,154.441,156.691,157.393,160.3,164.206,166.618,170.524,172.936,175.348,179.758,183.664,185.914,186.616,193.528,197.434,201.34,205.75,208.0,208.702,213.112,215.524,218.269,221.176,225.082,227.989,231.895,236.305,240.211,244.117,246.367,247.069,251.479,255.385,257.797,264.205,268.111,272.017,276.427,278.677,279.379,283.789,287.695,291.106,295.012" svgx:width="0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.61,0.5,0.44,0.25,0.55,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.5,0.44,0.39,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">alemtuzumab course. The relative mean difference between base-</text>
   <text y="353.061" x="62.362,64.774,67.186,71.596,75.502,77.752,79.993,83.899,88.309,92.719,94.969,97.21,100.621,105.031,109.441,112.852,116.758,121.168,125.578,129.484,133.894,136.306,138.556,140.797,143.209,145.621,152.533,156.439,160.849,165.259,167.671,172.081,174.493,177.904,180.154,182.395,186.301,189.712,192.124,194.536,201.448,205.354,207.766,211.672,216.082,218.332,220.573,222.985,227.395,230.302,234.712,239.122,243.532,247.942,250.192,252.433,254.845,259.255,263.161,265.411,267.652,270.559,274.969,277.876,284.788,289.198,291.61,295.516,298.018" svgx:width="0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.28,0.28,0.78,0.44,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.55,0.44,0.39,0.28,0.28,0.78,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">line and subsequent timepoints estimated through the formula: </text>
   <text y="364.059" x="62.362,65.269,70.363,72.775,79.687,83.593,88.003,92.413,94.825,99.235,101.647,104.554,110.467,114.373,117.784,121.69,124.102,126.514,130.924,134.83,137.737,140.149,146.062,149.968,153.379,157.285,159.697,162.109,166.519,170.425,172.585,175.249,179.155,183.565,187.975,190.639,194.05,196.462,200.872,205.282,207.694,210.601,213.013,216.919,220.825,225.235,229.141,233.047,235.711,240.121,243.028,245.692,248.104,252.514,256.42,259.084,263.494,265.906,268.651,271.558,275.464,278.371,282.277,286.687,290.593,294.499,298.0" svgx:width="0.33,0.61,0.28,0.78,0.44,0.5,0.5,0.28,0.5,0.28,0.33,0.67,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.33,0.28,0.67,0.44,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.25,0.44,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.44,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(Timepoint-Baseline)/Baseline, and significance of the differences </text>
   <text y="375.057" x="62.362,64.774,68.68,72.091,74.503,78.409,82.819" svgx:width="0.28,0.44,0.39,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tested.</text>
   <text y="386.055" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="386.055" x="95.554,100.423,106.921,110.917,115.417,117.919,122.419,125.416,129.916,132.418,136.918,140.914,143.11,147.61,151.606,154.108,156.61,160.606,165.106,167.608,171.109,173.305,176.302,179.299,183.799,190.801,192.997,197.497,199.693,205.192,209.692,212.689,217.189,221.689,225.685,229.681,234.181,236.377,239.878,242.38,244.882,248.878,252.379,254.629,256.33,262.828,265.825,268.327,272.323,275.32,277.516,281.512,284.014,288.01,295.012" svgx:width="0.61,0.72,0.44,0.5,0.28,0.5,0.33,0.5,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.61,0.5,0.33,0.5,0.5,0.44,0.44,0.5,0.25,0.39,0.28,0.28,0.44,0.39,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.44,0.28,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Twenty-nine patients from 6 European sites. After alem-</text>
   <text y="397.053" x="62.362,64.864,69.364,73.36,77.86,84.862,88.858,93.358,95.608,97.858,99.55,105.553,112.051,116.551,121.627,123.877,125.569,128.071,132.571,139.573,144.073,148.573,153.073,157.069,161.569,164.071,168.067,171.568,173.818,175.51,180.01,184.006,188.002,190.999,194.995,198.991,202.492,206.488,210.988,213.238,214.93,217.927,220.924,225.424,232.426,234.676,236.368,240.868,245.368,247.618,249.31,251.812,256.312,258.562,260.254,264.754,269.254,276.751,279.001,284.5,289.0,293.5,298.0" svgx:width="0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.25,0.25,0.55,0.67,0.72,0.5,0.56,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.5,0.83,0.25,0.61,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tuzumab, CD4+ lymphocytes decreased from 45 to 14%.Th17 </text>
   <text y="408.051" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,96.346,99.163,103.159,105.661,108.478,116.479,120.979,125.479,127.981,130.798,135.298,139.798,142.615,146.116,148.618,153.118,157.618,160.12,163.117,165.619,169.615,173.611,178.111,180.613,183.43,187.93,191.926,194.923,197.425,201.421,203.923,206.425,210.925,215.425,218.242,224.74,228.736,231.733,235.729,238.546,243.046,247.546,251.047,255.043,258.04,262.54,266.536,271.036,273.853,276.355,280.855,283.51,289.009,293.509,298.009" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.28,0.25,0.89,0.5,0.5,0.28,0.25,0.5,0.5,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.44,0.33,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.61,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased at M18; no significant variation were observed in Th1 </text>
   <text y="419.049" x="62.362,66.358,70.354,72.856,75.358,78.859,81.109,83.62,88.291,91.288,95.788,99.784,102.286,104.959,108.955,113.455,117.955,120.628,123.625,129.124,132.121,136.621,141.121,143.794,148.294,152.29,156.286,159.283,163.279,167.275,170.776,174.772,179.272,181.774,184.447,189.451,193.951,198.451,202.951,207.451,209.701,212.212,217.711,224.209,229.213,233.794,236.044,238.717,241.714,247.213,250.21,254.71,259.21,261.883,265.879,270.379,274.879,277.552,280.549,286.048,289.045,293.545,298.045" svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.61,0.33,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.28,0.25,0.56,0.5,0.5,0.5,0.5,0.25,0.25,0.61,0.72,0.56,0.51,0.25,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cells. T-bet and IL-23 decreased; Foxp3, TGFÎ², IL-10 and IL-27 </text>
   <text y="430.047" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,96.346,98.596,99.334,102.331,105.328,109.828,116.83,119.08,119.818,127.819,132.319,134.569,135.316,137.818,142.318,144.568,145.315,153.316,157.816,162.316,164.566,167.392,172.576,175.573,179.569,184.069,186.319,187.066,191.062,195.058,197.56,200.062,202.312,203.05,206.551,211.051,215.047,219.043,221.545,224.542,227.044,231.04,233.29,234.028,237.529,242.029,246.529,251.029,254.026,258.022,261.523,265.024,267.526,272.026,276.022,278.272,279.01,282.007,286.507,291.007,295.003" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.89,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.89,0.5,0.5,0.25,0.25,0.61,0.33,0.44,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased from M6 to M24. Treg cell specific suppressive func-</text>
   <text y="441.045" x="62.362,64.864,67.366,71.866,76.366,78.616,79.498,83.998,88.498,90.748,91.63,99.631,105.634,110.305,112.555,113.437,117.433,121.933,124.435,128.935,131.932,134.929,138.925,142.921,146.917,149.419,151.921,156.421,160.417,162.667,163.387,168.886,173.386,177.886,180.136,181.018,185.014,189.514,194.014,196.264,196.984,202.483,206.983,211.483,215.983,218.233,219.115,223.111,227.107,229.609,232.111,234.361,235.243,237.745,242.245,246.241,249.238,253.234,257.23,260.731,264.727,269.227,271.477,272.359,276.859,281.359,283.861,288.361,290.611,291.493,295.489,297.991" svgx:width="0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.89,0.67,0.56,0.25,0.55,0.44,0.5,0.28,0.5,0.33,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.61,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.5,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.5,0.5,0.28,0.5,0.25,0.55,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion on MBP auto-reactive Th1 and Th17 cell increased only at </text>
   <text y="452.043" x="62.362,70.363,74.863,79.363,81.613,83.908,90.406,94.906,98.902,101.899,105.895,109.891,113.392,115.687,118.189,122.689,126.685,128.98,133.48,137.98,144.982,149.482,153.478,156.475,158.77,163.27,166.267,168.4,173.584,176.581,180.577,185.077,187.372,191.368,195.364,197.866,200.368,203.869,206.164,210.16,214.66,219.16,221.455,223.957,228.457,232.453,234.955,237.952,240.247,244.747,249.247,253.243,256.24,260.236,262.738,265.24,267.535,271.036,275.536,280.036,284.536,287.533,291.529,295.03" svgx:width="0.89,0.5,0.5,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.61,0.33,0.44,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.33,0.25,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">M24, whereas the number of Treg cells and their overall suppres-</text>
   <text y="463.041" x="62.362,65.863,70.363,73.36,75.241,78.238,82.738,87.238,91.234,93.736,96.238,100.738,105.238,107.119,111.619,114.121,118.621,120.502,125.002,129.502,132.004,133.885,137.386,139.888,144.388,148.888,151.39,154.387,156.889,160.885,164.881,169.381,171.883,174.385,178.885,180.766,184.762,189.262,193.258,197.758,202.258,206.254,208.135,212.635,217.135,220.132,222.634,227.134,231.634,233.515,236.017,240.517,244.513,246.394,249.391,253.891,256.393,258.895,263.395,269.893,272.89,277.39,281.89,284.14,286.021,291.025,293.527,298.027" svgx:width="0.39,0.5,0.33,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.28,0.5,0.25,0.5,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.25,0.56,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sor function did not significantly change during the follow-up. Six </text>
   <text y="474.039" x="62.362,65.359,69.355,71.857,75.853,80.353,83.854,87.85,91.351,93.601,95.122,101.62,105.616,108.613,112.609,114.859,116.38,120.88,125.38,128.881,132.877,135.874,140.374,144.37,148.87,151.12,152.641,155.143,159.643,161.893,163.423,167.923,170.173,171.703,176.203,180.199,182.701,185.203,189.199,193.699,196.201,199.702,201.952,204.202,205.723,212.221,216.721,218.971,220.501,225.001,228.997,232.993,237.493,240.49,243.487,247.483,251.983,255.979,259.975,262.225,263.746,268.246,271.243,273.493,275.023,278.524,282.52,287.02,291.016,294.013,298.009" svgx:width="0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.39,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.5,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.33,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.44,0.5,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">relapses were observed in 5 patients. No occurrence of severe </text>
   <text y="485.037" x="62.362,66.358,70.858,73.36,77.86,80.362,87.364,94.366,98.866,103.366,107.362,109.612,114.112,116.614,120.115,124.111,128.107,131.608,135.604,139.105,141.355,145.855,148.852,151.102,155.602,160.102,163.603,166.105,170.605,175.105,178.102,182.602,185.104,189.604,192.106,195.607,202.609" svgx:width="0.44,0.5,0.28,0.5,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.5,0.5,0.39,0.28,0.5,0.5,0.33,0.5,0.28,0.5,0.28,0.39,0.78,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">autoimmune diseases or dysthyroidism.</text>
   <text y="496.035" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="496.035" x="114.787,120.286,124.786,128.782,131.698,136.198,140.698,144.694,147.691,151.687,154.189,156.691,159.607,163.603,166.105,170.101,177.103,179.605,184.105,188.101,192.601,199.603,203.599,208.099,211.096,213.598,218.098,222.598,227.098,231.094,235.09,239.59,242.506,248.509,255.007,259.507,264.583,267.499,270.001,274.501,281.503,286.003,290.503,295.003" svgx:width="0.61,0.5,0.44,0.25,0.5,0.5,0.44,0.33,0.44,0.28,0.28,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.44,0.5,0.78,0.44,0.5,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The overall alemtuzumab-induced CD4+ lympho-</text>
   <text y="507.033" x="62.362,66.358,70.858,73.36,77.356,79.255,83.755,87.751,92.251,94.753,98.749,101.251,103.753,108.253,112.753,114.652,121.654,124.156,128.656,133.156,135.658,137.557,140.554,144.55,147.052,151.048,153.55,157.546,159.445,161.947,166.447,168.346,170.848,175.348,179.344,181.243,184.24,188.236,192.736,197.236,201.232,203.734,206.236,210.736,215.236,217.135,221.635,224.632,226.531,234.532,239.536,241.435,245.935,248.437,251.938,255.934,259.93,263.431,267.427,269.326,273.322,277.318,279.82,282.322,286.822,289.324,291.826,295.741,297.991" svgx:width="0.44,0.5,0.28,0.44,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.78,0.28,0.5,0.5,0.28,0.25,0.33,0.44,0.28,0.44,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.89,0.56,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">cyte depletion might relate to the reduction of MS disease activity. </text>
   <text y="518.031" x="62.362,67.861,72.361,76.357,78.607,79.804,82.306,86.806,90.802,93.799,97.795,101.791,105.292,109.288,111.538,112.735,117.235,120.232,122.482,123.679,127.18,131.68,136.18,140.68,143.677,147.673,151.174,154.675,159.175,162.172,164.422,165.619,169.615,174.115,176.617,181.117,185.617,188.119,192.619,196.615,200.116,202.366,203.563,206.56,212.059,215.056,219.556,224.056,226.306,229.303,234.802,237.799,242.299,246.799,249.049,254.548,261.046,266.05,270.631,272.881,274.078,278.074,282.574,287.074,289.324,290.521,295.021,298.018" svgx:width="0.61,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.5,0.25,0.61,0.72,0.56,0.51,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The increase of suppressor cytokines IL-27,IL-10,TGFÎ² and of </text>
   <text y="529.029" x="62.362,70.363,76.366,81.37,84.367,87.868,92.368,96.364,100.36,102.862,105.859,108.361,112.357,114.337,119.521,122.518,126.514,131.014,133.156,136.657,141.157,145.657,150.157,153.154,157.15,160.651,164.152,168.652,171.649,173.791,176.788,181.288,185.788,189.784,192.286,194.788,199.288,203.788,205.93,209.926,214.426,218.926,221.428,225.928,228.07,232.57,236.566,241.066,245.062,247.204,250.201,254.197,257.698,262.198,264.7,267.202,271.198,275.698,277.84,280.342,284.842,286.984,289.486,293.986,297.982" svgx:width="0.89,0.67,0.56,0.33,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.61,0.33,0.44,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.5,0.33,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MBP-specific Treg suppressor function could have resulted in the </text>
   <text y="540.027" x="62.362,66.862,70.858,74.854,77.851,81.847,85.843,89.344,93.34,95.788,100.288,103.285,105.571,110.242,113.239,117.739,121.735,124.237,126.487,128.935,135.937,140.437,144.937,149.437,151.939,155.935,158.437,160.939,165.439,169.939,172.387,174.889,179.389,183.385,185.833,189.829,194.329,196.831,199.333,202.33,208.333,214.831,219.835,222.283,226.783,230.779,233.281,237.781,242.281,246.781,250.777,255.277,257.779,261.775,264.277,266.779,271.279,273.727,278.227,281.224,283.51,289.009,293.509,298.009" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.61,0.33,0.5,0.44,0.28,0.25,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.67,0.72,0.56,0.25,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.61,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decrease of T-bet, modulating the anti-CNS pathogenicity of Th1 </text>
   <text y="551.025" x="62.362,66.358,70.858,75.358,77.275,82.774,87.274,91.774,96.274,98.353,102.349,106.345,108.847,111.349,114.85,117.1,119.017,124.516,129.016,133.012,135.091,138.088,142.588,145.585,148.087,152.587,156.583,159.58,161.659,166.159,168.238,172.738,176.734,180.73,183.727,185.806,188.308,192.808,197.308,201.808,204.805,207.307,211.303,214.3,221.302,223.381,226.378,230.878,233.38,235.882,240.382,246.88,249.877,254.377,258.877,260.956,264.952,269.452,273.952,276.454,280.954,283.033,287.533,290.53,295.03" svgx:width="0.44,0.5,0.5,0.25,0.61,0.5,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.33,0.5,0.33,0.28,0.5,0.44,0.33,0.25,0.5,0.25,0.5,0.44,0.44,0.33,0.25,0.28,0.5,0.5,0.5,0.33,0.28,0.44,0.33,0.78,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and Th17 cells. The further 2 year long-term follow-up could pro-</text>
   <text y="562.023" x="62.362,66.862,69.364,73.864,77.86,80.605,83.107,87.607,90.604,95.104,98.101,105.103,109.099,111.601,114.103,118.603,123.103,125.848,130.348,134.848,137.593,140.095,144.595,148.591,151.336,153.838,156.34,163.342,165.844,170.344,174.844,177.589,182.089,185.086,187.831,191.332,195.832,200.332,203.833,207.829,212.329,216.829,220.825,225.325,227.827,230.572,234.568,239.068,243.568,246.565,250.066,254.062,257.563,260.308,264.808,267.805,270.55,274.546,277.048,281.044,288.046,290.548,295.048" svgx:width="0.5,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.5,0.33,0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.28,0.78,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.5,0.39,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.44,0.28,0.44,0.78,0.28,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">vide information on the timing of subsequent courses of alemtu-</text>
   <text y="573.021" x="62.362,66.358,70.858,77.86,81.856,86.356,88.606,91.108,95.608,97.858,100.36,104.86,109.36,111.862,116.362,118.864,123.364,127.864,131.86,134.362,136.612,141.112,145.108,147.61,150.112,154.108,158.608,161.11,164.611" svgx:width="0.44,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">zumab in individual patients.</text>
   <text y="605.025" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P957</text>
   <text y="616.023" x="62.362,67.861,70.363,75.367,79.867,84.367,86.869,89.371,96.868,101.368,106.372,108.622,112.123,116.119,118.621,122.617,126.613,129.61,132.112,136.612,140.608,143.11,147.61,149.86,154.36,157.357,160.354,164.35,168.346,171.343,173.593,178.093,183.097,186.094,188.596,193.096,197.092,202.096,205.093,210.097,214.093,218.089,221.59,225.586,230.59,233.587,236.089,241.093,245.593,247.843,251.839,255.835,258.337,260.839,264.34,266.59,270.586,275.086" svgx:width="0.61,0.28,0.56,0.5,0.5,0.28,0.28,0.83,0.5,0.56,0.25,0.39,0.44,0.28,0.44,0.44,0.33,0.28,0.5,0.44,0.28,0.5,0.25,0.5,0.33,0.33,0.44,0.44,0.33,0.25,0.5,0.56,0.33,0.28,0.5,0.44,0.56,0.33,0.56,0.44,0.44,0.39,0.44,0.56,0.33,0.28,0.56,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Fingolimod selectively affect antigen-presenting cells ex </text>
   <text y="627.021" x="62.362,66.862,69.364,73.864,78.364,80.614,85.114,90.118,95.122" svgx:width="0.5,0.28,0.5,0.5,0.25,0.5,0.56,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">vivo and </text>
   <text y="627.021" x="97.372,99.874,104.374,106.624,110.62,113.122,115.624,119.125" svgx:width="0.28,0.5,0.25,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">in vitro</text>
   <text y="627.021" x="123.625,125.875,128.377,133.381,135.631,143.128,148.132,150.634,153.631,156.133,161.137,163.639,167.635,169.885,173.386,177.382,179.884,183.88,187.876,192.376,195.877,198.379" svgx:width="0.25,0.28,0.56,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;"> in multiple sclerosis</text>
   <text y="638.019" x="62.362,68.86,71.11,76.609,81.109,85.609,92.611,96.607" svgx:width="0.72,0.25,0.61,0.5,0.5,0.78,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">K Thomas</text>
   <text y="635.583" x="100.108" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="638.103" x="103.033,105.283,107.533,114.031,116.281,122.779,126.775,129.277,133.777,138.277" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.28,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, U Hainke</text>
   <text y="635.583" x="142.272" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="638.103" x="145.197,147.447,149.697,155.196,157.446,162.45,166.446,170.946" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Sehr</text>
   <text y="635.583" x="173.943" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="638.103" x="176.868,179.118,181.368,186.867,189.117,194.121,198.117,202.617,207.117,209.619,212.121,216.621,220.617,223.119" svgx:width="0.25,0.25,0.61,0.25,0.56,0.44,0.5,0.5,0.28,0.28,0.5,0.44,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T SchultheiÃŸ</text>
   <text y="635.583" x="227.619" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="638.103" x="230.544,232.794,235.044,240.543,242.793,248.292,250.794,254.79,261.792,265.293,268.794,272.79" svgx:width="0.25,0.25,0.61,0.25,0.61,0.28,0.44,0.78,0.39,0.39,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, T Ziemssen</text>
   <text y="635.583" x="277.289" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="646.581" x="62.36" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="649.103" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,111.529,116.029,119.53,124.03,126.532,129.034,133.534,136.036,138.286,144.784,148.285,152.281,155.782,160.282,164.278,168.778,171.028,173.278,179.281,183.277,187.777,190.279,194.275,197.776,200.026,204.526,207.028,209.278,215.281,217.783,220.285,224.785,227.287,231.283,235.783,238.285,240.535,246.538,250.534,255.034,258.535,263.035,266.536,270.532,273.034,277.03,281.53,285.526,289.522,291.772" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.72,0.5,0.39,0.5,0.28,0.28,0.5,0.28,0.25,0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.28,0.25,0.67,0.28,0.28,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.39,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Hospital Dresden, Center of Clinical Neuroscience, </text>
   <text y="660.101" x="62.362,68.86,72.361,76.357,79.858,84.358,88.354,92.854,95.104,97.354,103.852,107.848,111.349,117.847,122.347,126.847" svgx:width="0.72,0.39,0.44,0.39,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Dresden, Germany</text>
   <text y="687.101" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="687.101" x="114.535,119.539,122.041,126.541,131.041,135.541,138.043,140.545,147.547,152.047,156.547,158.374,161.371,166.375,171.874,178.372,181.369,183.196,185.698,189.199,191.026,195.526,200.026,204.526,211.024,215.524,217.351,221.347,224.848,226.675,231.679,236.179,240.85,242.677,245.674,249.67,253.666,257.662,262.162,264.664,269.164,272.161,273.988,277.984,282.484,286.48,288.982,293.482,297.982" svgx:width="0.56,0.28,0.5,0.5,0.5,0.28,0.28,0.78,0.5,0.5,0.25,0.33,0.56,0.61,0.72,0.33,0.25,0.28,0.39,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.44,0.39,0.25,0.56,0.5,0.56,0.25,0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.25,0.44,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Fingolimod (FTY) is known as S1P receptor analog </text>
   <text y="698.099" x="62.362,64.864,69.364,73.36,75.862,78.508,85.51,89.506,94.006,96.508,100.504,103.006,107.002,110.503,113.149,115.651,120.151,124.651,127.153,131.653,134.155,136.657,139.159,143.659,148.159,150.805,155.305,158.302,160.948,163.45,167.95,174.952,179.452,183.952,188.452,192.448,196.948,199.45,203.446,206.092,210.088,214.588,217.585,221.581,225.082,228.583,231.229,234.226,237.223,241.723,248.725,251.371,253.873,258.373,265.375,269.875,274.375,277.021,281.521,286.021,290.521,294.517,298.018" svgx:width="0.28,0.5,0.44,0.28,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.33,0.44,0.39,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.78,0.5,0.5,0.25,0.5,0.5,0.5,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">that mediates inhibition of lymphocyte egress from lymph nodes </text>
   <text y="709.097" x="62.362,64.864,69.364,71.866,76.366,79.129,83.629,87.625,90.622,93.124,97.624,102.124,106.12,109.117,113.113,115.615,118.378,122.878,125.38,129.88,134.38,138.88,141.13,143.893,149.896,153.892,157.393,159.895,164.395,168.391,171.154,173.656,178.156,182.152,185.653,189.649,192.412,196.408,199.243,202.24,206.236,210.232,212.734,216.235,218.998,222.994,225.496,228.997,233.497,236.26,240.76,243.262,246.259,250.255,254.251,256.753,260.749,265.249,268.012,275.014,279.514,284.014,288.514,291.016,295.012" svgx:width="0.28,0.5,0.28,0.5,0.25,0.5,0.44,0.33,0.28,0.5,0.5,0.44,0.33,0.44,0.28,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.25,0.67,0.44,0.39,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.39,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.44,0.28,0.39,0.5,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">into peripheral blood. Beside these effects also directed modula-</text>
   <text y="720.095" x="62.362,64.864,67.366,71.866,76.366,78.355,82.855,85.852,87.841,90.343,97.345,104.347,108.847,113.347,117.343,119.332,123.328,127.324,129.826,132.328,134.317,138.817,143.317,147.817,152.317,154.819,158.815,161.317,163.819,168.319,172.819,176.32,178.309,180.811,184.312,186.301,190.801,193.303,196.804,200.8,205.3,208.801,212.302,216.298,220.798,223.048,225.037,231.535,235.531,240.031,244.531,247.528,250.03,252.532,255.034,259.03,261.019,265.015,269.011,271.513,274.015,277.516,279.505,282.502,289.0,295.003,298.0" svgx:width="0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.39,0.25,0.5,0.28,0.39,0.44,0.5,0.39,0.39,0.44,0.5,0.25,0.25,0.72,0.44,0.5,0.5,0.33,0.28,0.28,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.33,0.72,0.67,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion of immune cell populations is discussed. Dendritic cells (DC) </text>
   <text y="731.093" x="62.362,66.358,70.858,75.358,77.608,79.597,86.599,91.099,95.599,100.099,104.095,108.595,111.097,115.093,118.594,120.844,122.833,125.83,133.831,138.331,141.328,143.578,145.567,149.563,152.56,156.556,158.806,160.795,165.295,168.292,172.792,175.789,179.785,183.286,186.787,189.289,193.789,198.289,202.285,204.787,207.037,209.026,213.022,217.522,220.024,222.526,227.026,231.022,235.522,237.772,239.761,244.261,247.258,251.254,254.755,258.751,263.251,265.753,268.255,272.755,277.255,279.505,281.494,285.49,289.486,291.988,294.49,297.991" svgx:width="0.44,0.5,0.5,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.33,0.89,0.5,0.33,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.33,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.44,0.5,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and monocytes (Mo) are professional antigen presenting cells </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M310.020 551.300 L351.770 551.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,313.013,319.511,324.515,330.518,333.515,335.765,336.971,341.471,344.468,348.464,352.964,356.96,360.461,362.963,365.96,369.956,372.458,374.96,379.46,383.96,386.21,387.416,390.413,394.409,396.911,400.907,405.407,409.403,413.903,416.405,418.655,419.861,424.361,427.358,431.858,435.854,439.85,443.351,446.852,450.848,454.349,456.599,457.805,462.305,465.302,467.552,468.758,471.26,475.76,480.26,484.256,486.758,490.754,493.004,494.21,496.712,503.714,510.716,515.216,519.716,522.218,524.72,529.22,531.47,532.676,536.672,541.172,545.672" svgx:width="0.33,0.72,0.56,0.67,0.33,0.25,0.55,0.5,0.33,0.44,0.5,0.44,0.39,0.28,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(APC) orchestrating relevant processes of innate immunity and </text>
   <text y="88.101" x="310.016,313.517,318.017,322.517,327.017,331.013,334.514,337.016,341.012,345.512,347.762,350.345,352.847,357.347,359.597,362.18,366.68,370.676,372.926,375.509,380.009,382.511,385.508,389.504,393.5,396.002,398.504,403.004,405.254,407.837,410.339,414.839,419.339,423.839,426.341,430.841,434.837,439.337,441.587,444.17,446.672,451.172,453.422,456.005,463.007,467.507,470.009,472.511,475.013,479.513,482.015,486.011,488.261,490.844,494.345,498.341,500.843,504.839,507.836,512.336,515.837,518.339,521.84,524.09,526.673,529.67,537.671,542.675,545.672" svgx:width="0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.5,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.55,0.33,0.89,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suggested to be directly involved in multiple sclerosis (MS) </text>
   <text y="99.099" x="310.016,314.516,318.512,321.014,325.514,330.014,334.514,338.51,343.01,347.006,350.507,353.009,356.51,358.76,361.01,361.865,367.364,371.864,375.86,378.11,379.127,386.129,390.629,394.13,396.632,398.882,399.899,402.896,405.893,409.889,414.389,418.889,422.885,427.385,429.887,432.137,433.154,437.654,440.651,445.151,447.653,452.153,455.15,457.652,461.648,468.65,475.652,479.648,482.15,486.65,489.647,494.147,496.397,497.414,501.914,506.414,513.416,517.412,521.912,524.162,525.179,529.679,532.181,536.681,541.181,545.681" svgx:width="0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.33,0.33,0.44,0.5,0.5,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.5,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.5,0.78,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pathogenesis. The most frequent proinflammatory human blood </text>
   <text y="110.097" x="310.016,316.514,322.517,324.398,326.9,330.401,332.282,334.784,339.284,343.28,345.161,348.662,353.162,356.159,360.155,364.151,366.653,369.155,373.151,377.651,379.532,383.033,385.535,389.531,394.031,400.529,406.532,408.782,410.663,413.66,416.162,418.043,420.545,424.046,425.927,429.923,433.424,436.925,441.425,448.427,452.423,456.923,458.804,461.306,465.806,469.802,472.304,474.185,476.687,483.689,490.691,495.191,499.691,504.191,511.193,515.693,520.193,524.693,527.195,531.191,533.693,538.193,541.19,545.69" svgx:width="0.72,0.67,0.25,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.33,0.44,0.44,0.28,0.28,0.44,0.5,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.25,0.33,0.28,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.78,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.5,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">DC is the so-called slanDC. It is assumed that immunomodulatory </text>
   <text y="121.095" x="310.016,318.017,323.021,324.911,327.413,330.41,334.406,338.402,340.904,347.906,351.902,356.402,358.904,360.794,364.295,366.797,369.794,373.79,376.292,380.288,384.788,387.29,391.286,394.787,396.677,399.179,403.679,407.675,410.177,414.677,419.177,421.679,426.179,430.679,432.569,437.573,443.072,449.237,451.127,455.123,459.623,464.123,468.623,472.619,474.509,477.011,481.511,486.011,488.513,491.51,495.506,499.502,502.004,503.894,507.89,510.725,513.722,517.718,521.714,524.216,527.717,529.607,534.107,538.607,540.335,545.672" svgx:width="0.89,0.56,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.56,0.61,0.72,0.25,0.44,0.5,0.5,0.5,0.44,0.25,0.28,0.5,0.5,0.28,0.33,0.44,0.44,0.28,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.5,0.25,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS treatment strategies including FTY evoke indirect effects on T </text>
   <text y="132.093" x="310.016,314.012,318.512,323.012,325.262,331.265,333.515,337.511,341.507,344.009,346.511,348.761,353.261,357.761,362.261,366.761,369.263,373.259,375.761,378.263,382.763,387.263,390.764,393.014,397.514,402.014,404.264,407.765,412.265,416.261,420.257,422.759,425.756,428.258,432.254,434.504,441.506,446.006,450.506,455.006,457.508,461.504,464.006,466.508,471.008,475.508,477.758,482.258,485.255,487.01,493.508,498.512,504.515,506.765,509.762,514.262,518.762,522.758,525.26,527.762,532.262,536.762" svgx:width="0.44,0.5,0.5,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.25,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.25,0.39,0.5,0.44,0.44,0.28,0.33,0.28,0.44,0.25,0.78,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.56,0.67,0.25,0.33,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and B cell populations by specific modulation of APC function.</text>
   <text y="143.091" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="143.091" x="355.385,360.254,364.754,366.635,370.631,375.131,379.127,381.629,386.129,390.125,392.627,396.623,398.504,402.5,405.335,408.332,412.328,416.324,418.826,422.327,424.208,428.708,431.705,433.586,438.59,444.089,450.254,452.135,456.635,461.135,463.016,465.518,470.018,474.014,475.895,478.397,482.897,487.397,491.393,493.895,497.891,499.772,502.274,509.276,516.278,520.778,525.278,529.274,531.155,534.656,539.156,542.657" svgx:width="0.61,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.56,0.61,0.72,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.44,0.28,0.44,0.25,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.39,0.5,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To evaluate effects of FTY on the innate immune sys-</text>
   <text y="154.089" x="310.016,312.518,316.514,323.516,325.766,328.268,332.768,335.018,343.019,348.023" svgx:width="0.28,0.44,0.78,0.25,0.28,0.5,0.25,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tem in MS.</text>
   <text y="165.087" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="165.087" x="348.707,355.205,358.706,360.902,364.898,369.398,371.594,376.094,378.596,383.096,387.596,389.792,394.292,397.289,401.789,404.291,408.287,412.283,414.785,417.035,419.231,423.731,426.233,430.733,435.233,439.733,441.929,448.427,452.423,455.924,458.12,462.62,465.617,469.613,476.111,480.611,482.807,485.804,488.801,493.301,500.303,502.499,510.5,515.504,517.7,522.2,526.196,528.698,531.2,535.196,539.696,542.198,545.699" svgx:width="0.72,0.39,0.25,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.25,0.5,0.28,0.5,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.33,0.44,0.72,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As ex vivo project, blood was drawn from MS patients </text>
   <text y="176.085" x="310.016,314.516,318.512,321.509,326.009,329.006,333.002,334.928,338.924,343.424,347.924,349.85,354.35,358.85,361.847,364.349,368.849,373.349,375.275,380.279,385.778,391.943,393.869,396.371,400.871,404.867,407.864,411.86,416.36,420.275,422.525,424.289,429.626,431.552,435.548,439.544,442.046,444.548,448.049,450.299,452.225,458.228,460.154,464.15,468.146,470.648,473.15,476.651,478.901,480.827,487.325,493.823,495.749,499.745,503.741,506.243,508.745,512.246,514.496,516.422,519.923,522.425,526.421,530.921,537.419,543.422,545.672" svgx:width="0.5,0.44,0.33,0.5,0.33,0.44,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.56,0.61,0.72,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.67,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.72,0.72,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">before and during FTY therapy. T cells, B cells, NK cells, slanDC, </text>
   <text y="187.083" x="310.016,316.019,322.517,327.017,332.093,338.591,344.594,346.556,350.552,355.052,359.552,361.514,369.515,374.015,375.977,382.475,386.471,389.468,393.464,395.426,399.422,403.922,407.918,410.42,414.92,418.916,422.912,427.412,429.374,433.874,438.374,440.336,444.674,451.172,457.175,462.179,464.141,468.137,470.639,472.601,477.101,479.603,482.438,485.435,489.431,492.428,496.424,500.924,503.426,505.388,507.89,510.392,517.394,521.39,525.89,530.39,532.892,537.392,539.894,543.395,545.645" svgx:width="0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.89,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.56,0.72,0.67,0.56,0.25,0.44,0.28,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.28,0.28,0.78,0.44,0.5,0.5,0.28,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD1+DC and Mo were analyzed by FACS at different timepoints. </text>
   <text y="198.081" x="310.016,316.514,320.015,322.265,323.453,327.953,331.949,334.451,338.447,340.949,343.451,347.447,351.947" svgx:width="0.72,0.39,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As detailed </text>
   <text y="198.081" x="355.385,359.381,363.377,365.627,366.815,370.811,373.313,377.309,381.809,384.806,387.308,391.808,394.058,395.246,399.242,401.744,404.246,407.414" svgx:width="0.44,0.44,0.25,0.55,0.44,0.28,0.44,0.5,0.33,0.28,0.5,0.25,0.55,0.44,0.28,0.28,0.39,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">ex vivo-in vitro</text>
   <text y="198.081" x="411.914,414.164,415.352,419.852,422.849,427.349,429.851,433.847,437.843,440.345,442.595,444.845,446.033,449.534,452.036,456.032,460.532,467.03,473.033,475.283,477.533,478.721,484.724,491.222,495.722,500.798,507.296,513.299,515.549,516.737,520.733,525.233,529.733,531.983,533.171,541.172,545.672" svgx:width="0.25,0.55,0.5,0.33,0.5,0.28,0.44,0.44,0.28,0.25,0.25,0.55,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.25,0.55,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.89,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> project, slanDC, CD1+DC and Mo </text>
   <text y="209.079" x="310.016,316.514,320.51,323.507,327.503,329.654,332.156,335.657,340.157,342.659,346.655,349.157,353.153,357.653,359.804,364.304,368.804,370.955,373.457,380.459,387.461,391.961,396.461,400.961,407.963,411.959,416.459,420.959,424.955,427.457,429.959,433.955,436.106,440.102,444.098,446.6,449.102,451.253,454.754,459.254,462.251,464.753,467.255,471.755,476.255,478.406,482.906,485.903,488.054,492.554,496.55,500.546,503.048,505.55,510.05,514.55,516.701,520.697,525.197,529.697,532.199,535.196,539.696,542.198,545.699" svgx:width="0.72,0.44,0.33,0.44,0.25,0.28,0.39,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.44,0.5,0.5,0.44,0.28,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.25,0.39,0.5,0.33,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">were isolated by immunomagnetic cell sorting of healthy controls </text>
   <text y="220.077" x="310.016,313.013,319.511,325.514,328.511,331.274,335.27,339.77,344.27,347.042,352.046,357.545,363.71,366.482,368.984,371.981,375.977,379.973,382.475,386.471,390.971,393.734,401.735,406.739,409.511,414.011,418.007,420.509,423.011,427.007,431.507,434.009,437.51,439.76,442.037,448.535,451.532,454.034,458.03,461.027,463.79,467.291,469.793,472.295,479.297,483.797,486.299,490.295,492.797,495.299,499.799,504.299,507.062,513.56,516.062,518.564,523.064,525.674,531.173,536.672,542.675" svgx:width="0.33,0.72,0.67,0.33,0.25,0.44,0.5,0.5,0.25,0.56,0.61,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.72,0.33,0.28,0.44,0.33,0.25,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.61,0.61,0.67,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(HC) and FTY treated MS patients. After stimulation with TLR-</text>
   <text y="231.075" x="310.016,314.516,317.018,321.518,323.768,325.577,328.079,330.581,335.081,339.077,343.577,348.077,351.578,353.828,355.637,358.139,362.639,364.889,366.698,371.198,374.195,378.191,381.692,385.688,390.188,394.184,398.18,400.43,402.239,406.739,409.736,411.986,413.795,417.791,422.291,425.792,429.788,434.288,438.284,442.28,444.53,446.339,450.839,453.836,456.086,457.895,462.899,468.398,474.563,476.813,478.622,483.122,486.119,488.369,490.178,495.182,500.681,506.18,509.177,513.677,518.177,522.677,526.178,530.678,535.178,539.174,541.676,545.672" svgx:width="0.5,0.28,0.5,0.25,0.55,0.28,0.28,0.5,0.44,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.39,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.61,0.72,0.33,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">2/4 ligands in presence or absence of FTY or FTY-phosphate </text>
   <text y="242.073" x="310.016,313.013,318.017,323.516,329.015,332.012,337.016,340.013,342.263,344.297,350.795,355.799,361.802,364.331,370.829,374.825,377.822,381.818,384.347,388.343,392.843,396.839,399.341,403.841,407.837,411.833,416.333,418.862,421.859,425.855,430.355,434.351,437.348,441.848,444.35,448.85,453.35,455.879,459.875,464.375,466.877,471.377,475.877,478.379,482.879,486.875,489.404,492.401,496.397,498.899,502.895,506.891,510.392,514.388,516.638,519.167,523.163,527.663,532.163,535.16,539.156,542.657" svgx:width="0.33,0.56,0.61,0.72,0.33,0.56,0.33,0.25,0.25,0.72,0.56,0.67,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.5,0.44,0.33,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(FTY-P), APC were analyzed regarding cytokine release, expres-</text>
   <text y="253.071" x="310.016,313.517,316.019,320.519,325.019,326.9,331.4,334.397,336.278,339.779,344.279,347.276,350.273,354.269,358.265,362.261,364.142,371.144,375.14,378.137,382.637,386.633,389.63,393.131,395.381,397.262,401.762,406.262,410.258,414.758,419.258,423.254,427.754,430.256,434.756,438.257,440.759,444.26,446.141,450.137,454.133,456.635,459.137,463.637,466.139,468.641,473.141,475.022,479.018,483.518,488.018,489.899,493.895,497.891,502.391,506.387,510.383,512.885,515.387,519.887,521.768,524.27,528.77,530.651,535.151,538.148,542.648" svgx:width="0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.25,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.28,0.5,0.25,0.5,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sion of surface markers, phagocytosis activity and capacity to pro-</text>
   <text y="264.069" x="310.016,317.018,321.518,324.02,328.016,330.266,334.766,337.763,342.263,344.765,347.267,350.264,354.26,357.257,361.253,363.755,366.257,370.757,375.257,377.507,381.503,386.003,390.503,392.753,397.253,399.755,402.59,405.587,409.583,412.58,416.576,421.076,423.578,426.08,430.076,432.578,435.08,439.58,444.08,446.33,450.83,453.827,455.915,460.586,463.583,467.579,471.575,474.077,476.579,480.08" svgx:width="0.78,0.5,0.28,0.44,0.25,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">mote proliferation and differentiation of T-cells.</text>
   <text y="275.067" x="310.016,316.469,320.42,323.876,328.835,331.292,334.244,337.7,340.652" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="275.067" x="343.118,346.07,350.525,352.991,356.942,361.397,363.863,368.318,370.775,375.23,379.685,382.151,386.102,390.557,394.508,396.965,401.42,404.876,407.333,410.789,413.255,417.206,421.157,423.614,426.071,428.537,432.992,437.447,444.404,448.858,452.809,455.761,458.227,462.682,465.634,468.1,474.058,480.511,484.966,487.171,489.637,495.595,502.048,506.503,508.969,512.92,517.375,521.831,524.297,530.255,536.708,541.163,545.663" svgx:width="0.33,0.5,0.25,0.44,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.39,0.25,0.44,0.44,0.28,0.28,0.25,0.5,0.5,0.78,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.25,0.25,0.67,0.72,0.5,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In ex vivo analysis cell number of CD4, CD8 and CD19 </text>
   <text y="286.065" x="310.016,312.473,316.928,323.885,328.34,332.795,337.25,341.201,345.656,348.113,352.064,355.52,357.653,362.108,366.059,370.01,372.962,376.913,380.864,384.32,388.271,392.725,394.858,398.809,401.761,404.218,408.169,411.121,413.254,415.711,418.663,422.614,426.565,429.022,435.979,439.93,444.385,446.842,448.975,451.432,455.887,458.344,460.801,463.258,467.209,469.666,472.123,476.578,481.033,483.238,485.371,491.824,496.279,500.23,503.182,507.133,511.084,514.54,516.673,520.129,522.586,526.537,530.992,537.445,543.403,545.653" svgx:width="0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.28,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.72,0.5,0.44,0.33,0.44,0.44,0.39,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lymphocytes decreased after treatment initiation, whereas slanDC, </text>
   <text y="297.063" x="310.016,315.974,322.427,326.882,331.913,338.366,344.324,346.259,350.21,354.665,359.12,361.055,369.011,373.466,375.401,379.856,383.807,388.262,390.719,392.654,396.11,398.567,402.518,406.973,409.43,413.381,415.316,419.771,424.226,427.178,429.635,434.09,438.544,440.479,444.934,449.389,451.324,458.281,462.736,467.191,469.648,474.103,476.038,478.99,483.445,485.902,488.359,492.814,499.267,501.202,505.657,510.112,512.317,514.252,519.211,524.665,530.785,532.72,536.671,541.126,545.626" svgx:width="0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.89,0.5,0.25,0.5,0.44,0.5,0.28,0.25,0.39,0.28,0.44,0.5,0.28,0.44,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.25,0.5,0.5,0.25,0.25,0.56,0.61,0.72,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD1+DC and Mo kept stable during 24 month follow up. FTY and </text>
   <text y="308.061" x="310.016,314.975,320.429,325.883,328.835,333.461,335.711,340.166,344.117,348.068,351.02,354.971,358.922,362.378,366.329,370.784,373.034,377.489,380.441,384.896,387.353,391.808,394.76,397.217,401.168,408.125,415.082,419.033,421.49,425.945,428.897,433.352,435.602,439.553,444.008,446.465,450.919,455.374,457.831,462.286,466.237,468.487,471.439,475.39,477.847,481.798,485.749,489.205,493.156,495.406,499.861,502.813,505.063,508.015,513.469,516.421,520.876,523.081,525.331,528.283,533.737,536.689,541.144,545.644" svgx:width="0.56,0.61,0.72,0.33,0.56,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.5,0.33,0.5,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.25,0.5,0.33,0.25,0.33,0.61,0.33,0.5,0.25,0.25,0.33,0.61,0.33,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">FTY-P decreased proinflammatory cytokine release of IL-6, IL-1b </text>
   <text y="319.059" x="310.016,313.967,318.422,322.877,324.902,330.356,336.809,341.768,344.72,348.671,350.858,353.315,357.77,359.957,363.413,365.87,369.821,374.276,380.729,386.687,388.892,391.079,397.037,403.49,407.945,412.976,419.429,425.387,427.574,431.525,435.98,440.435,442.622,450.578,455.033,457.22,461.171,464.123,466.58,470.531,473.483,475.67,481.124,486.083,491.042,493.229,497.684,500.636,502.823,507.782,514.235,520.688,522.875,526.331,528.788,531.245,538.202,542.657" svgx:width="0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.33,0.44,0.25,0.28,0.5,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.25,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.89,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.61,0.56,0.56,0.25,0.5,0.33,0.25,0.56,0.72,0.72,0.25,0.39,0.28,0.28,0.78,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">and TNF-a in slanDC, CD1+DC and Mo after LPS or PGN stimu-</text>
   <text y="330.057" x="310.016,312.473,316.424,318.881,321.338,325.793,330.248,332.453,334.541,340.499,344.954,351.911,356.366,360.317,363.269,367.22,371.675,373.763,376.22,380.675,382.763,389.216,395.174,397.379,399.467,402.923,405.38,409.331,413.786,420.239,426.197,428.285,432.74,435.692,437.78,442.739,448.193,454.313,456.401,458.858,461.81,465.761,469.712,472.169,476.12,480.575,482.663,487.118,491.069,493.526,495.983,499.934,504.389,506.846,510.302,512.39,515.846,520.301,524.756,531.209,535.16,539.615,541.703,545.699" svgx:width="0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.67,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.72,0.67,0.25,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.5,0.33,0.25,0.56,0.61,0.72,0.25,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lation. Compared to HC, slanDC of FTY treated patients showed a </text>
   <text y="341.055" x="310.016,314.471,318.422,322.373,325.325,329.276,333.227,336.683,340.634,345.089,347.339,348.68,351.632,357.086,360.038,364.493,366.743,368.084,372.035,376.49,380.945,383.195,384.536,387.488,392.942,395.894,400.349,404.804,407.054,408.395,411.851,415.802,419.753,422.704,426.655,429.112,431.569,436.024,440.479,442.729,444.07,448.021,450.973,453.43,457.381,460.333,462.583,463.924,469.378,474.337,479.296,481.501,483.751,485.092,489.547,494.002,496.459,498.709,500.05,504.001,508.456,510.706,512.047,514.504,518.959,522.91,525.862,529.813,533.764,537.22,541.171,545.671" svgx:width="0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.61,0.56,0.56,0.25,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decreased IL-6 and IL-1b secretion after LPS, but an increased </text>
   <text y="352.053" x="310.016,312.968,318.422,321.374,325.829,330.284,332.534,333.425,336.881,340.832,344.783,347.735,351.686,354.143,356.6,361.055,365.51,367.715,369.965,370.856,376.31,380.765,385.22,388.172,392.123,395.579,399.035,401.492,405.947,410.401,412.651,413.542,417.997,420.949,423.199,424.09,427.546,432.001,434.953,437.905,441.856,445.807,449.758,452.008,452.899,459.856,463.807,466.264,470.719,473.671,477.622,480.079,482.536,486.991,491.446,493.696,494.587,498.538,502.993,507.448,509.698,510.589,514.54,518.491,520.948,523.405,527.86,531.811,534.268,536.725,541.18,545.68" svgx:width="0.33,0.61,0.33,0.5,0.5,0.25,0.55,0.39,0.44,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">IL-10 secretion. Expression of surface maturation and activation </text>
   <text y="363.051" x="310.016,316.973,320.924,323.876,328.331,332.282,335.234,338.69,340.94,343.775,346.232,350.687,354.638,357.095,361.55,366.005,368.462,372.917,377.372,379.622,382.457,388.415,394.868,399.323,403.778,406.028,408.863,412.814,417.268,421.723,423.973,426.808,432.766,439.219,443.674,448.129,450.379,453.214,459.667,463.618,466.57,470.521,472.771,475.606,480.061,484.516,490.969,495.424,497.674,500.509,503.461,507.412,511.867,516.322,518.779,522.73,525.187,529.138,533.593,535.843,538.678,541.135,545.635" svgx:width="0.78,0.44,0.33,0.5,0.44,0.33,0.39,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.5,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.72,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">markers including CD83 and CD86 were down regulated in </text>
   <text y="374.049" x="310.016,313.472,315.929,319.88,324.335,330.788,336.746,338.996,340.067,344.018,348.473,352.928,355.178,356.249,362.207,368.66,373.115,378.146,384.599,390.557,392.807,393.878,397.829,400.781,403.238,407.189,410.141,412.391,413.462,418.421,423.875,429.995,432.245,433.316,437.267,441.722,445.673,448.13,450.587,454.538,458.993,463.448,467.399,469.604,471.854,472.925,477.884,483.338,489.458,491.708,492.779,497.234,501.689,504.146,506.396,507.467,511.922,516.377,518.834,521.084,522.155,527.114,532.568,538.022,540.974,545.645" svgx:width="0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.55,0.44,0.33,0.28,0.44,0.33,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.44,0.5,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.25,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.5,0.5,0.28,0.25,0.55,0.56,0.61,0.72,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">slanDC and CD1+DC after FTY challenge. FTY but not FTY-P </text>
   <text y="385.047" x="310.016,314.471,317.423,321.374,324.326,326.783,329.735,333.686,337.637,340.094,347.051,351.002,355.457,357.914,360.11,362.567,367.022,371.477,373.934,378.389,380.846,383.303,387.254,391.709,393.905,397.361,399.818,403.769,408.224,414.677,420.635,422.831,426.782,431.237,435.692,437.888,443.846,450.299,454.754,459.785,466.238,472.196,474.392,478.847,482.798,487.253,491.204,495.659,500.113,502.57,507.025,511.48,513.676,519.634,526.087,530.542,532.738,536.689,541.144,545.644" svgx:width="0.5,0.33,0.44,0.33,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.5,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.67,0.72,0.5,0.25,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">pre-treatment inhibited slanDC and CD1+DC depending CD4 and </text>
   <text y="396.045" x="310.016,315.974,322.427,326.882,329.132,329.942,335.234,337.484,338.456,342.407,346.358,348.815,351.272,353.522,354.494,358.949,361.901,366.356,368.813,371.27,374.222,378.173,381.125,385.076,387.533,389.99,394.445,398.9,401.105,403.355,404.327,409.286,414.74,420.86,423.11,424.082,428.033,432.488,436.943,439.193,440.165,445.124,450.578,456.032,458.984,463.61,465.86,466.832,469.784,473.735,478.19,482.645,486.596,490.547,495.002,497.252,498.224,500.681,505.135,509.086,511.336,512.308,516.259,520.714,523.171,525.628,528.085,530.542,534.997,537.247,538.219,542.674,545.671" svgx:width="0.67,0.72,0.5,0.25,0.55,0.61,0.25,0.55,0.44,0.44,0.28,0.28,0.25,0.55,0.5,0.33,0.5,0.28,0.28,0.33,0.44,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.56,0.61,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.61,0.72,0.33,0.56,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">CD8 T cell proliferation. FTY and FTY-P reduced the ability of </text>
   <text y="407.043" x="310.016,315.47,320.429,325.388,328.34,331.796,334.253,336.71,343.667,348.122,350.579,354.53,356.987,360.938,365.393,367.643,368.57,372.026,374.483,378.434,382.889,389.342,395.3,397.55,398.477,402.428,406.883,411.338,413.588,414.515,420.473,426.926,431.381,436.412,442.865,448.823,451.073,452.0,454.457,458.912,461.162,462.089,466.544,469.496,473.951,480.908,485.363,487.82,491.771,494.021,494.948,499.403,501.86,504.65,507.602,511.553,514.505,518.456,522.911,525.368,527.825,531.776,534.232,536.689,541.144,545.644" svgx:width="0.61,0.56,0.56,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.5,0.56,0.72,0.67,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.33,0.5,0.78,0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">LPS-stimulated slanDC and CD1+DC to promote differentiation </text>
   <text y="418.041" x="310.016,314.471,317.423,319.673,321.185,325.64,329.591,332.048,336.503,340.454,342.704,344.216,350.174,356.627,361.082,363.332,364.682,369.308,372.26,376.211,380.162,382.619,385.076,388.532,390.782,392.294,394.751,399.206,401.663,406.118,408.368,409.88,412.832,417.791,424.244,427.196,431.651,434.603,438.554,443.009,447.464,450.415,454.366,457.822,461.278,463.735,468.19,472.645,474.895,476.245,481.699,486.154,490.609,492.859,494.371,498.322,502.273,504.73,507.187,510.643,512.848,515.098,516.61,524.566,529.021,531.271,532.783,536.734,541.189,545.689" svgx:width="0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.5,0.44,0.25,0.55,0.67,0.72,0.5,0.25,0.55,0.61,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.28,0.5,0.25,0.55,0.33,0.56,0.72,0.33,0.5,0.33,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.61,0.5,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.89,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of naÃ¯ve CD4 T-cells into IFN-g-expressing Th1 cells. Mo and </text>
   <text y="429.039" x="310.016,313.472,315.929,319.88,324.335,330.788,336.746,338.951,343.406,347.357,351.308,354.26,358.211,362.162,365.618,369.569,374.024,376.229,378.686,383.141,385.346,389.801,394.255,398.206,402.661,407.116,411.067,415.522,417.979,422.434,425.89,428.347,431.803,434.008,437.959,441.91,446.365,450.316,454.267,456.724,459.181,463.636,465.841,469.792,472.744,475.201,479.152,482.104,484.309,489.268,494.722,500.842,503.047,506.998,511.453,515.908,518.113,523.072,528.526,533.98,536.932,540.892" svgx:width="0.39,0.28,0.44,0.5,0.72,0.67,0.25,0.5,0.44,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.44,0.5,0.5,0.44,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.44,0.44,0.5,0.44,0.44,0.28,0.28,0.5,0.25,0.44,0.33,0.28,0.44,0.33,0.25,0.56,0.61,0.72,0.25,0.44,0.5,0.5,0.25,0.56,0.61,0.72,0.33,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">slanDC decreased in phagocytosis capacity after FTY and FTY-P.</text>
   <text y="440.037" x="310.016,316.514,321.014,326.018,330.014,332.516,337.52,341.021,343.523,348.023,353.027,356.528,359.525" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="440.037" x="361.424,366.428,370.928,373.925,375.824,378.326,382.826,386.822,388.721,391.718,394.22,397.217,400.718,403.22,405.119,407.621,410.123,417.125,421.121,423.02,429.518,433.514,435.413,439.913,442.91,446.906,450.407,454.403,458.903,461.405,463.304,467.804,470.306,473.303,477.299,481.295,483.797,485.696,488.198,495.2,502.202,506.702,511.202,515.702,522.704,527.204,531.704,536.204,538.706,542.702" svgx:width="0.56,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.33,0.39,0.28,0.25,0.28,0.28,0.78,0.44,0.25,0.72,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.5,0.28,0.33,0.44,0.44,0.28,0.25,0.28,0.78,0.78,0.5,0.5,0.5,0.78,0.5,0.5,0.5,0.28,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">For the first time we present direct immunomodula-</text>
   <text y="451.035" x="310.016,312.518,317.018,320.015,324.515,326.45,330.446,333.281,336.278,340.274,344.27,346.772,350.273,352.208,356.708,359.705,361.64,366.644,372.143,378.308,380.243,384.743,389.243,391.178,395.678,398.18,401.015,404.012,408.008,411.005,415.001,419.501,422.003,423.443,429.941,434.945,440.948,442.883,446.384,450.884,455.384,459.884,464.384,468.884,473.384,475.886,479.882,482.384,484.886,489.386,493.886,497.387,499.322,501.824,506.324,508.259,512.255,516.755,521.255,523.757,526.754,530.75,534.251,536.753,538.688,541.19,545.69" svgx:width="0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.56,0.61,0.72,0.25,0.5,0.5,0.25,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.25,0.72,0.56,0.67,0.25,0.39,0.5,0.5,0.5,0.5,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.5,0.28,0.33,0.44,0.39,0.28,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tory effects of FTY on different APC subpopulations in contrast to </text>
   <text y="462.033" x="310.016,314.516,319.016,323.516,330.014,334.514,337.412,339.914,346.916,351.416,355.412,359.408,361.91,364.808,369.308,373.808,376.544,381.881,384.779,388.775,393.275,397.775,400.673,406.676,409.574,412.076,416.576,423.578,428.078,432.578,437.078,441.074,445.574,448.076,452.072,454.97,457.472,460.469,464.465,467.3,470.297,472.799,476.795,481.295,483.797,488.297,492.797,495.047,497.783,503.282,507.782,511.778,515.279,519.275,522.173,525.17,529.166,532.667,537.167,539.669,542.171,545.672" svgx:width="0.5,0.5,0.5,0.72,0.5,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.61,0.25,0.44,0.5,0.5,0.25,0.67,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.28,0.33,0.44,0.33,0.33,0.28,0.44,0.5,0.28,0.5,0.5,0.25,0.25,0.61,0.5,0.44,0.39,0.44,0.25,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">known impact on T and B lymphocyte trafficking. These results </text>
   <text y="473.031" x="310.016,313.517,318.017,322.517,327.017,331.013,334.514,337.016,339.266,341.768,346.268,350.264,352.514,357.014,361.514,365.015,368.516,371.018,375.518,378.02,380.522,383.024,385.526,390.026,392.276,396.776,399.773,402.023,404.525,411.527,416.027,420.023,424.019,426.521,428.771,433.271,437.771,439.859,445.196,447.446,451.442,455.438,457.94,460.442,462.692,467.192,470.189,474.689,479.189,482.186,486.182,493.184,500.186,502.688,507.188,511.688,513.938,518.438,522.938,525.188,530.192,535.691,541.028" svgx:width="0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.39,0.39,0.28,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.61,0.25,0.44,0.44,0.28,0.28,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.78,0.78,0.28,0.5,0.5,0.25,0.5,0.5,0.25,0.56,0.61,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">suggest the possibility of impact on T cell programming by FTY.</text>
   <text y="506.034" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P958</text>
   <text y="517.032" x="310.016,315.02,318.017,322.013,326.513,331.517,336.017,338.267,341.768,344.765,349.265,352.262,356.258,358.508,363.512,368.516,373.016,377.012,384.509,389.009,393.005,397.505,402.509,405.011,410.015,414.011,417.008,419.51,423.506,427.007,429.257,433.757,438.761,443.765,446.015,451.019,453.521,458.021,462.521,467.525,469.775,472.277,476.777,484.274,489.278,494.282,498.782,502.778,507.278,510.275,514.271" svgx:width="0.56,0.33,0.44,0.5,0.56,0.5,0.25,0.39,0.33,0.5,0.33,0.44,0.25,0.56,0.56,0.5,0.44,0.83,0.5,0.44,0.5,0.56,0.28,0.56,0.44,0.33,0.28,0.44,0.39,0.25,0.5,0.56,0.56,0.25,0.56,0.28,0.5,0.5,0.56,0.25,0.28,0.5,0.83,0.56,0.56,0.5,0.44,0.5,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Steady state pharmacokinetics and blood lymphocyte </text>
   <text y="528.03" x="310.016,314.012,318.008,321.509,326.513,331.013,336.017,339.518,343.514,347.015,349.265,351.767,356.771,359.021,364.025,368.021,372.521,375.023,378.02,383.024,387.524,389.774,393.275,398.279,403.283,406.28,410.276,414.272,417.269,420.77,423.02,428.024,432.524,436.025,440.021,445.025,447.275,453.773,456.275,459.272,464.276,466.526,473.024,478.523,483.023,487.523,492.023,496.523,501.023,503.273,505.523,510.023" svgx:width="0.44,0.44,0.39,0.56,0.5,0.56,0.39,0.44,0.39,0.25,0.28,0.56,0.25,0.56,0.44,0.5,0.28,0.33,0.56,0.5,0.25,0.39,0.56,0.56,0.33,0.44,0.44,0.33,0.39,0.25,0.56,0.5,0.39,0.44,0.56,0.25,0.72,0.28,0.33,0.56,0.25,0.72,0.61,0.5,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">responses in healthy subjects dosed with XP23829, a </text>
   <text y="539.028" x="310.016,315.02,319.52,324.02,328.016,330.518,332.768,335.765,340.769,348.266,352.766,356.762,359.264,363.26,365.51,370.01,374.006,376.508,381.512,383.762,387.758,391.259,394.256,398.252,402.248,404.498,407.495,411.995,415.991,418.241,425.738,430.742,433.244,436.241,438.743,443.747,446.249,450.245,452.495,455.996,459.992,462.494,466.49,470.486,474.986,478.487,480.989" svgx:width="0.56,0.5,0.5,0.44,0.28,0.25,0.33,0.56,0.83,0.5,0.44,0.28,0.44,0.25,0.5,0.44,0.28,0.56,0.25,0.44,0.39,0.33,0.44,0.44,0.25,0.33,0.5,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">novel fumaric acid ester for multiple sclerosis</text>
   <text y="550.026" x="310.016,315.515,317.765,322.769,325.271,329.267,331.769,336.269,343.271,347.267" svgx:width="0.61,0.25,0.56,0.28,0.44,0.28,0.5,0.78,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">L Steinman</text>
   <text y="547.583" x="351.766" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="550.103" x="354.691,356.941,359.191,365.194,368.695,370.945,375.949,380.449" svgx:width="0.25,0.25,0.67,0.39,0.25,0.56,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, RJ Fox</text>
   <text y="547.583" x="384.949" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="550.103" x="387.874,390.124,392.374,398.872,401.122,406.621,409.123,412.624,416.125,418.627" svgx:width="0.25,0.25,0.72,0.25,0.61,0.28,0.39,0.39,0.28,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Lissin</text>
   <text y="547.583" x="423.127" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="550.103" x="426.052,428.302,430.552,436.051,438.301,444.304,446.806,450.802,453.799" svgx:width="0.25,0.25,0.61,0.25,0.67,0.28,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, L Clark</text>
   <text y="547.583" x="458.299" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="550.103" x="461.224,463.474,465.724,472.222,474.472,480.475,484.975,489.475,493.975" svgx:width="0.25,0.25,0.72,0.25,0.67,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, K Cundy</text>
   <text y="547.583" x="498.474" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="558.581" x="310.017" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="561.103" x="312.941,317.441,319.943,324.443,328.943,331.445,335.945,339.446,343.946,346.196,350.696,354.692,359.192,363.692,368.192,370.694,372.944,377.444,379.946,382.196,389.693,393.689,398.189,400.691,404.687,407.189,411.689,415.685,417.935,420.185,426.683,430.679,435.179,439.679,443.18,445.682,452.18,456.176,460.676,463.178,465.428,469.928,472.43,474.68,480.683,484.679,489.179,492.68,497.18,499.682,504.182,508.682,512.678,514.928,519.428,523.928,528.428" svgx:width="0.5,0.28,0.5,0.5,0.28,0.5,0.39,0.5,0.25,0.5,0.44,0.5,0.5,0.5,0.28,0.25,0.5,0.28,0.25,0.83,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.25,0.72,0.44,0.5,0.5,0.39,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.28,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Stanford School of Medicine, Department of Neurology and </text>
   <text y="572.101" x="310.016,316.019,320.015,324.515,328.016,332.516,335.018,339.518,344.018,346.52,350.516,355.016,357.518,359.768,364.268,368.264,370.766,374.762,379.262,383.258,387.254,390.755,393.005,395.255,399.755,402.257,406.757,411.257,413.759,418.259,421.76,426.26,428.51,430.76,436.763,442.262,444.512,446.762,453.26,457.76,460.262,462.764,466.76,471.26,473.51,478.01,480.512,485.012,487.514,491.51,495.011,497.261" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.5,0.28,0.25,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.39,0.25,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.39,0.5,0.25,0.25,0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurological Sciences, Stanford, CA, United States, </text>
   <text y="569.583" x="499.509" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="572.103" x="502.434,508.437,510.939,514.935,518.931,522.927,525.429,529.929,534.429,538.929" svgx:width="0.67,0.28,0.44,0.44,0.44,0.28,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Cleveland </text>
   <text y="583.101" x="310.014,316.017,318.519,321.021,325.521,328.023,332.019,334.269,339.768,344.268,348.768,353.268,357.768,362.268,364.77,367.272,371.772,376.272,378.522,380.772,388.269,392.265,394.767,397.269,401.265,405.765,408.015,414.018,418.014,422.514,425.016,429.012,432.513,434.763,437.265,441.765,445.266,447.516,455.013,459.513,462.015,464.517,467.019,471.519,474.021,478.017,480.267,484.767,488.763,491.265,495.261,498.762,503.262,506.763,509.265,512.766" svgx:width="0.67,0.28,0.28,0.5,0.28,0.44,0.25,0.61,0.5,0.5,0.5,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.83,0.44,0.28,0.28,0.44,0.5,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.39,0.25,0.83,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.5,0.44,0.28,0.44,0.39,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Clinic Foundation, Mellen Center for Multiple Sclerosis </text>
   <text y="594.099" x="310.014,315.018,318.519,322.515,327.015,329.517,336.015,340.011,344.511,347.013,349.263,353.763,358.263,362.763,365.013,370.512,374.508,378.009,382.005,386.505,390.006,394.002,398.502,400.752,403.002,409.005,411.507,415.503,419.499,423.495,425.997,430.497,434.997,439.497,441.747,443.997,450.495,456.993,459.243,461.493,467.991,472.491,474.993,477.495,481.491,485.991,488.241,492.741,495.243,499.743,502.245,506.241,509.742,511.992" svgx:width="0.56,0.39,0.44,0.5,0.28,0.72,0.44,0.5,0.28,0.25,0.5,0.5,0.5,0.25,0.61,0.44,0.39,0.44,0.5,0.39,0.44,0.5,0.25,0.25,0.67,0.28,0.44,0.44,0.44,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.72,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Treatment and Research, Cleveland, OH, United States, </text>
   <text y="602.583" x="310.016" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="605.103" x="312.941,318.44,322.436,326.936,331.436,336.935,341.435,344.936,347.438,349.688,351.938,354.935,359.435,363.431,365.681,367.931,370.181,374.681,379.181,383.681,386.183,390.683,392.933,398.936,401.438,405.938,409.439,413.939,416.189,418.439,424.442,429.941,432.191,434.441,440.939,445.439,447.941,450.443,454.439,458.939,461.189,465.689,468.191,472.691,475.193,479.189" svgx:width="0.61,0.44,0.5,0.5,0.61,0.5,0.39,0.28,0.25,0.25,0.33,0.5,0.44,0.25,0.25,0.25,0.5,0.5,0.5,0.28,0.5,0.25,0.67,0.28,0.5,0.39,0.5,0.25,0.25,0.67,0.61,0.25,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.5,0.28,0.5,0.28,0.44,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">XenoPort, Inc., Santa Clara, CA, United States</text>
   <text y="632.103" x="310.016,316.019,320.519,324.515,329.519,334.019,337.853,342.353,347.357,352.361,357.365,360.362" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="632.103" x="362.837,369.335,374.339,378.839,383.339,387.839,392.339,396.839,399.314,401.816,405.317,407.792,411.788,416.288,418.763,421.265,425.765,430.265,434.765,439.265,443.261,445.763,448.265,452.765,456.761,459.236,463.736,466.733,471.233,475.733,478.73,483.23,487.73,490.205,494.705,497.702,500.177,507.179,511.679,516.179,520.679,527.681,531.677,534.179,538.679,543.179,545.681" svgx:width="0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.28,0.5,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.25,0.5,0.33,0.25,0.78,0.5,0.5,0.5,0.78,0.44,0.28,0.5,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">XP23829 is an innovative prodrug of monomethyl </text>
   <text y="643.101" x="310.016,313.013,317.513,324.515,328.511,331.508,335.504,338.006,342.002,344.747,347.744,355.745,363.746,368.75,371.747,373.997,376.742,379.244,383.744,387.74,390.485,393.986,397.982,404.984,408.98,411.725,415.721,419.717,422.219,424.721,429.221,433.217,435.962,442.964,446.96,449.462,453.458,457.958,462.458,464.96,467.462,469.964,473.96,476.705,481.205,484.202,488.702,493.202,497.702,501.698,505.694,510.194,512.939,517.439,521.939,524.684,529.184,531.686,538.688,542.684" svgx:width="0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.33,0.89,0.89,0.56,0.33,0.25,0.25,0.28,0.5,0.44,0.25,0.39,0.44,0.78,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.78,0.44,0.28,0.44,0.5,0.5,0.28,0.28,0.28,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.28,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fumarate (MMF), the same active metabolite produced by dime-</text>
   <text y="654.099" x="310.016,312.518,317.018,321.518,324.02,326.27,329.294,332.291,336.791,343.793,347.789,350.786,354.782,357.284,361.28,363.53,366.554,369.551,376.049,384.05,389.054,392.051,394.301,396.551,399.575,405.578,409.574,414.074,418.574,422.57,425.072,427.574,432.074,436.574,440.075,442.325,445.349,447.851,452.351,454.601,457.625,462.125,464.627,469.127,473.627,478.127,480.377,483.401,485.903,490.403,497.405,501.905,506.405,510.905,514.901,519.401,521.903,525.899,529.4,531.65,534.674,538.67,541.667,545.663" svgx:width="0.28,0.5,0.5,0.28,0.25,0.55,0.33,0.5,0.78,0.44,0.33,0.44,0.28,0.44,0.25,0.55,0.33,0.72,0.89,0.56,0.33,0.25,0.25,0.55,0.67,0.44,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25,0.55,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">thyl fumarate (DMF). Reductions in blood lymphocytes are </text>
   <text y="665.097" x="310.016,314.516,319.016,323.516,330.014,334.514,336.764,340.76,343.595,346.592,350.588,354.584,357.086,360.587,362.837,367.337,370.334,372.584,375.581,380.081,387.083,391.079,394.076,396.578,400.574,402.824,406.82,410.816,413.318,417.818,420.068,424.064,427.565,430.067,434.063,437.06,440.561" svgx:width="0.5,0.5,0.5,0.72,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.5,0.78,0.44,0.33,0.28,0.44,0.25,0.44,0.44,0.28,0.5,0.25,0.44,0.39,0.28,0.44,0.33,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">known effects of fumaric acid esters.</text>
   <text y="676.095" x="310.016,317.018,322.022,325.019,329.015,333.011,336.008,338.51,343.01,347.006,350.507,353.504" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="676.095" x="358.472,363.341,367.841,370.091,372.809,375.311,379.811,384.311,388.307,391.808,394.31,396.812,401.312,405.308,407.81,411.806,414.056,416.774,419.276,423.776,427.772,430.022,432.74,436.241,438.743,442.739,446.735,451.235,455.735,457.985,460.703,464.204,466.706,470.702,473.204,477.2,479.45,482.168,486.668,491.168,495.164,498.161,505.163,509.159,513.155,517.655,522.155,524.657,529.157,533.153,535.655,538.157,542.153,545.654" svgx:width="0.61,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.44,0.44,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.44,0.25,0.55,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.5,0.5,0.28,0.5,0.44,0.28,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To investigate the steady state pharmacokinetics </text>
   <text y="687.093" x="310.016,313.013,318.017,324.515,327.512,329.762,332.084,336.08,340.58,345.08,347.33,349.652,353.153,357.149,360.146,364.142,366.644,371.144,373.394,375.716,380.216,383.213,385.463,387.785,390.287,396.785,401.285,403.535,405.857,408.854,413.354,416.351,423.353,427.853,430.355,434.351,436.853,439.355,443.855,448.355,451.856,454.106,456.428,460.928,463.925,466.175,468.497,474.995,479.999,484.499,488.999,493.499,497.999,502.499,504.749,507.071,511.067,515.567,520.067,522.317,524.639,531.137,539.138,543.422,545.672" svgx:width="0.33,0.56,0.72,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.39,0.44,0.33,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.5,0.25,0.55,0.33,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.72,0.89,0.56,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PK) and safety of two formulations of XP23829 and DMF, </text>
   <text y="698.091" x="310.016,312.518,317.018,321.014,323.516,328.016,332.516,335.018,339.518,344.018,346.268,350.768,355.268,359.768,363.764,370.766,373.268,377.264,379.514,383.51,388.01,392.006,396.506,401.006,405.002,408.503,410.753,413.255,417.755,420.005,422.507,427.007,434.009,438.509,443.009,447.509,451.505,456.005,458.507,462.503,464.753,468.749,473.249,477.749,482.249,484.751,488.252" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.44,0.78,0.28,0.44,0.25,0.44,0.5,0.44,0.5,0.5,0.44,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.25,0.44,0.5,0.5,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">including dynamic changes in lymphocyte counts.</text>
   <text y="709.089" x="310.016,318.512,322.508,325.505,330.509,335.009,340.013,343.514,346.511" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="709.089" x="351.623,357.122,361.622,364.124,367.625,369.875,372.737,375.734,379.73,384.23,388.73,393.23,400.232,402.734,406.73,410.726,415.226,417.476,419.726,422.588,427.088,431.588,436.088,440.588,443.09,447.086,450.083,454.583,457.085,459.587,464.087,468.587,470.837,473.087,475.949,480.449,482.951,486.947,490.943,494.939,499.439,503.939,506.936,510.932,515.432,519.932,522.434,525.431,529.931,532.433,534.935,538.931,543.431,545.681" svgx:width="0.61,0.5,0.28,0.39,0.25,0.55,0.33,0.44,0.5,0.5,0.5,0.78,0.28,0.44,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.44,0.33,0.5,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.28,0.44,0.44,0.44,0.5,0.5,0.33,0.44,0.5,0.5,0.28,0.33,0.5,0.28,0.28,0.44,0.5,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This randomized, double-blind, placebo-controlled, </text>
   <text y="720.087" x="310.016,317.018,321.518,324.02,326.522,329.024,333.524,336.026,340.022,342.272,343.37,347.366,350.867,354.863,358.859,363.359,367.859,370.361,374.861,379.361,381.611,383.861,384.959,389.459,392.456,396.452,398.954,401.951,406.451,410.951,414.452,418.448,420.698,421.796,425.297,427.799,432.299,436.799,441.299,443.549,444.647,449.147,452.144,454.394,455.492,460.496,464.996,467.993,474.995,479.495,481.997,485.993,488.495,490.997,495.497,499.997,503.498,505.748,506.846,511.346,513.596,514.694,517.691,522.191,526.187,528.689,532.685,537.185,541.181,545.681" svgx:width="0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.44,0.39,0.44,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.25,0.55,0.5,0.33,0.44,0.28,0.33,0.5,0.5,0.39,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.56,0.5,0.33,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.25,0.55,0.33,0.5,0.44,0.28,0.44,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">multiple ascending, oral-dose study of Formulations 1 (delayed </text>
   <text y="731.085" x="310.016,313.013,317.009,319.511,323.507,327.503,331.004,335.0,337.997,340.247,341.021,345.017,349.517,354.017,356.267,357.041,361.541,363.791,364.565,367.562,371.558,376.058,378.56,382.556,387.056,391.556,395.552,400.052,402.302,403.076,406.073,410.069,412.571,416.567,420.563,424.064,428.06,431.057,433.307,434.081,438.581,441.578,443.828,444.602,451.1,456.104,460.604,465.104,469.604,474.104,478.604,480.854,481.628,488.126,492.122,495.623,497.873,498.647,502.643,507.143,511.643,516.143,520.643,524.639,527.141,531.137,535.637,537.887,538.661,541.163,545.663" svgx:width="0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.44,0.5,0.5,0.44,0.5,0.25,0.55,0.33,0.44,0.28,0.44,0.44,0.39,0.44,0.33,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">release) and 2 (extended release) of XP23829 was conducted in </text>
  </g>
 </g>
</svg>
